Clinical trial
Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study
NCT06372184 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Washed Microbiota Transplantation for Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Study
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2024
- Completion date
- October 1, 2029
- Enrollment
- 32 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.